Biomarker changes in suspected idiopathic normal-pressure hydrocephalus patients undergoing external lumbar drainage: a pilot study
- PMID: 39219196
- PMCID: PMC11399721
- DOI: 10.3325/cmj.2024.65.328
Biomarker changes in suspected idiopathic normal-pressure hydrocephalus patients undergoing external lumbar drainage: a pilot study
Abstract
Aim: To examine whether changes in biomarker concentrations in patients with idiopathic normal-pressure hydrocephalus (iNPH) during 72 h of external lumbar drainage (ELD) can differentiate between responders and non-responders.
Methods: Twenty patients with clinical and neuroradiological signs of iNPH underwent ELD over a period of 72 h. During this period, changes in cerebrospinal fluid (CSF) concentrations of biomarkers (amyloid-β, total and phosphorylated tau proteins) and intracranial pressure were monitored, and the volume of drained CSF was measured. Changes in the concentrations of selected biomarkers at three time points (0, 36, and 72 h) during ELD were tested for association with changes in clinical condition.
Results: Ten patients showed significant clinical improvement after ELD, quantified as a difference of two or more points on the Mini-Mental State Examination and/or Japanese iNPH grading scale. The concentration of all tested biomarkers increased during the first 36 h. Respondents had higher Aβ 1-42 at all time points, with a significant difference seen after 72 h. They also had a significantly higher Aβ1-42/Aβ1-40 ratio at all time points.
Conclusion: A gradual increase in Aβ 1-42 concentration during three-day ELD represents a possible positive prognostic factor for the placement of permanent CSF drainage in patients with iNPH.
Figures


Similar articles
-
The longitudinal profile of CSF markers during external lumbar drainage.J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1130-3. doi: 10.1136/jnnp.2008.171686. Epub 2009 Jun 16. J Neurol Neurosurg Psychiatry. 2009. PMID: 19535354
-
Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.J Clin Neurosci. 2014 Aug;21(8):1398-403. doi: 10.1016/j.jocn.2013.11.039. Epub 2014 May 14. J Clin Neurosci. 2014. PMID: 24836892
-
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.J Alzheimers Dis. 2021;80(4):1629-1642. doi: 10.3233/JAD-201361. J Alzheimers Dis. 2021. PMID: 33720890 Free PMC article.
-
Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.J Alzheimers Dis. 2019;68(1):267-279. doi: 10.3233/JAD-180816. J Alzheimers Dis. 2019. PMID: 30741681
-
Temporary Drainage of Cerebrospinal Fluid for Diagnosis and Treatment of Hydrocephalus.Neurosurg Clin N Am. 2025 Apr;36(2):233-246. doi: 10.1016/j.nec.2024.12.002. Epub 2025 Feb 5. Neurosurg Clin N Am. 2025. PMID: 40054975 Review.
Cited by
-
The promise of cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus.Croat Med J. 2024 Aug 31;65(4):303-304. doi: 10.3325/cmj.2024.65.303. Croat Med J. 2024. PMID: 39219193 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources